ÌÇÐÄvlog

This cohort study assesses the performance of ABCD-10 compared with SCORTEN for patients with epidermal necrolysis in Singapore.

This cohort study calculates annual age-standardized incidence rates for histopathologically confirmed first and multiple cutaneous squamous cell carcinoma per patient and estimates future cutaneous squamous cell carcinoma incidence rates up to 2027.

This cohort study uses registry-based data of US organ transplant recipients to assess the incidence of sebaceous carcinoma and patient survival among solid organ transplant recipients from 1987 through 2017.

These randomized clinical trials examine the efficacy and safety of VP-102, a drug-device combination containing cantharidin, 0.7% (w/v), in treatment of patients with molluscum contagiosum.

This cohort study uses data from the QSkin Sun and Health study to assess the incidence rate and risk factors for keratoacanthoma among residents of Queensland, Australia.

This randomized clinical trial assesses the efficacy and safety of 4 mg and 2 mg of baricitinib in combination with background topical corticosteroid therapy in adults with moderate to severe AD who previously had an inadequate response to topical corticosteroid therapy.

This secondary analysis of 2 randomized clinical trials compares patient-reported outcomes of treatment with risankizumab vs ustekinumab and placebo in psoriasis symptoms, health-related quality of life, and mental health among patients with moderate to severe psoriasis.